Literature DB >> 21863321

Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on left-ventricular mechanical dyssynchrony as assessed by phase analysis of gated SPECT myocardial perfusion imaging.

Ji Chen1, Hosakote Nagaraj, Pradeep Bhambhani, Dustin E Kliner, Prem Soman, Ernest V Garcia, Jaekyeong Heo, Ami E Iskandrian.   

Abstract

Patients with hypertrophic cardiomyopathy (HCM) may have delayed septal activation and left ventricular (LV) mechanical dyssynchrony, and may improve after alcohol septal ablation (ASA). This study used phase analysis of gated SPECT myocardial perfusion imaging (MPI) to evaluate septal activation and LV dyssynchrony in HCM patients pre- and post-ASA. Phase analysis was applied to 28 controls, and 32 HCM patients having rest MPI pre- and post-ASA to assess septal-lateral mechanical activation delay (SLD) and consequent LV dyssynchrony. In addition, phase analysis was applied to another group of 30 patients having serial MPI to measure variability of the LV dyssynchrony parameters on serial studies. ASA significantly reduced SLD and improved LV synchrony in the HCM patients with SLD < 0° due to earlier activation of the lateral wall relative to the septum. Based on the measured variability, 12 HCM patients had significant (Z < -1.65, P < 0.05) and 4 had moderate (Z < -1.00, P < 0.15) improvement in LV synchrony post-ASA. SLD < 0° predicted improvement in LV synchrony after ASA with a sensitivity of 81% and a specificity of 88%. SLD and LV dyssynchrony were frequent in HCM patients. HCM patients, whose septal activation became later than lateral activation, had significant reduction in septal activation delay and improvement in LV synchrony after ASA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21863321      PMCID: PMC3348360          DOI: 10.1007/s10554-011-9942-y

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  32 in total

Review 1.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors:  Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

2.  Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation.

Authors:  Jeroen J Bax; Thomas H Marwick; Sander G Molhoek; Gabe B Bleeker; Lieselot van Erven; Eric Boersma; Paul Steendijk; Ernst E van der Wall; Martin J Schalij
Journal:  Am J Cardiol       Date:  2003-11-15       Impact factor: 2.778

Review 3.  Hypertrophic cardiomyopathy. Clinical spectrum and treatment.

Authors:  E D Wigle; H Rakowski; B P Kimball; W G Williams
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

4.  Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.

Authors:  R A Nishimura; J M Trusty; D L Hayes; D M Ilstrup; D R Larson; S N Hayes; T G Allison; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1997-02       Impact factor: 24.094

Review 5.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

6.  Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.

Authors:  L Fananapazir; N D Epstein; R V Curiel; J A Panza; D Tripodi; D McAreavey
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

7.  DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.

Authors:  A K Slade; N Sadoul; L Shapiro; L Chojnowska; J P Simon; R C Saumarez; B Dodinot; A J Camm; W J McKenna; E Aliot
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

8.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

Review 9.  The management of hypertrophic cardiomyopathy.

Authors:  P Spirito; C E Seidman; W J McKenna; B J Maron
Journal:  N Engl J Med       Date:  1997-03-13       Impact factor: 91.245

10.  Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT.

Authors:  Mark J Boogers; Ji Chen; Rutger J van Bommel; C Jan Willem Borleffs; Petra Dibbets-Schneider; Bernies van der Hiel; Imad Al Younis; Martin J Schalij; Ernst E van der Wall; Ernest V Garcia; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-10-17       Impact factor: 9.236

View more
  5 in total

1.  LV dyssynchrony as assessed by phase analysis of gated SPECT myocardial perfusion imaging in patients with Wolff-Parkinson-White syndrome.

Authors:  Chun Chen; Dianfu Li; Changqing Miao; Jianlin Feng; Yanli Zhou; Kejiang Cao; Michael S Lloyd; Ji Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-25       Impact factor: 9.236

2.  Phase analysis of myocardial SPECT to understand mechanisms of disease and therapy.

Authors:  Prem Soman
Journal:  J Nucl Cardiol       Date:  2014-10       Impact factor: 5.952

3.  Medical, surgical and interventional management of hypertrophic cardiomyopathy with obstruction.

Authors:  Sammy Elmariah; Michael A Fifer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

4.  Mechanical dyssynchrony and diastolic dysfunction are common in LVH: a pilot correlation study using Doppler echocardiography and CZT gated-SPECT MPI.

Authors:  Szu-Ying Tsai; Shan-Ying Wang; Yu-Chien Shiau; Yen-Wen Wu
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

5.  Mechanical aberrations in hypetrophic cardiomyopathy: emerging concepts.

Authors:  Dimitrios Ntelios; Georgios Tzimagiorgis; Georgios K Efthimiadis; Haralambos Karvounis
Journal:  Front Physiol       Date:  2015-08-19       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.